Page 34 - SaxoCell Annual Report22/23
P. 34

Workflow of a large-scale expansion of NKG2C+ NK cells with PC-3 feeder cells at a ratio of 10:1 in bioreactors with gas-
             permeable soil membrane. 5 x 10^5 PC-3 feeder cells were fed on the day of isolation, day 3 and day 7



             The  "NK4Therapy"  project  contributes  to  advancing  a  NKG2C-positive  NK  cell-based
             immunotherapy of cancer through an optimized GMP-compliant manufacturing process for clinical
             use.




















                                                                                                              29
   29   30   31   32   33   34   35   36   37   38   39